Skip to search formSkip to main contentSkip to account menu

Bufexamac

Known as: p-Butoxyphenylacethydroxamic Acid, p Butoxyphenylacethydroxamic Acid, Benzeneacetamide, 4-butoxy-N-hydroxy- 
A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Lysine deacetylases inhibitors (KDACIs) are used in basic research, and many are being investigated in clinical trials for… 
Highly Cited
2014
Highly Cited
2014
The relevance of contact allergens is subject to constant change due to changing exposures according to consumers’ preferences… 
Highly Cited
2011
Highly Cited
2011
The development of selective histone deacetylase (HDAC) inhibitors with anti-cancer and anti-inflammatory properties remains… 
Highly Cited
2009
Highly Cited
2009
Background:  There is little information regarding the risk of sensitization associated with topical atopic dermatitis (AD… 
Review
2009
Review
2009
Background.  Many interventions have been described for inherited epidermolysis bullosa (EB), but it is unclear which are… 
Highly Cited
2004
Highly Cited
2004
Allergic contact dermatitis (ACD) affects approximately 7% of the general population. To evaluate the frequency of ACD in… 
Review
1994
Review
1994
4 patients developed an erythema‐multiforme‐like reaction following acute contact dermatitis from 2 different bufexamac… 
1985
1985
We report on 161 patients suffering from inflammatory dermatoses on hands, forearms, and lower legs who had been initially… 
1977